Badalamenti, PharmD, Vincent C., Jill W. Buckley, PharmD, and Eric T. Smith, PharmD. “Safety of EMBEDA® (morphine Sulfate and Naltrexone Hydrochloride) Extended-Release Capsules: Review of Postmarketing Adverse Events During the First Year”. Journal of Opioid Management 8, no. 2 (March 1, 2012): 115–125. Accessed May 2, 2024. https://wmpllc.org/ojs/index.php/jom/article/view/780.